Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.

Source:http://linkedlifedata.com/resource/pubmed/id/16640329

J. Med. Chem. 2006 May 4 49 9 2689-702

Download in:

View as

General Info

PMID
16640329